Ajith Prasanna Kannangara

Suggest Changes
We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
BACKGROUND Various combination therapies are used in refractory cutaneous T-cell lymphoma (CTCL). Although bexarotene has been studied in combination with psoralen photochemotherapy (PUVA), IFN-alpha(More)
© 2008 The Authors 1373 JEADV 2008, 22, 1365–1401 Journal compilation © 2008 European Academy of Dermatology and Venereology to 87% and from 30% to 47%, respectively. Unlike other sarcomas, the high(More)
  • 1